Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$107.26 USD
+3.34 (3.21%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $107.14 -0.12 (-0.11%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ABT 107.26 +3.34(3.21%)
Will ABT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABT
Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
Jobless Claims Increased More Than Expected
Abbott (ABT) Q2 Earnings Surpass Estimates, Margins Expand
Other News for ABT
Unlocking Intrinsic Value: Analysis of Abbott Laboratories
7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio
Abbott Laboratories Breaks Above 200-Day Moving Average - Bullish for ABT
LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)